Stopped: Due to COVID-19 pandemic, patients stopped attending treatment in person. Patients have not returned to in-person treatment, and there is no plan for this to occur. The study could not be conducted virtually in secure manner.
This study has two aims: 1) to test the validity of an eating disorder symptom checklist against an established clinical interview; and 2) to examine whether providing eating disorder patients with visual graphs of their symptom frequency in the early sessions of active treatment will lead to higher numbers of patients achieving a "rapid response" (65% reduction in symptoms in the first 4 weeks of treatment). Groups where patients receive visual graphs of symptom frequency will be compared with groups where patients do not receive visual graphs of symptom frequency on rates of rapid response to cognitive behavior treatment for eating disorders.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in eating disorder symptoms from baseline
Timeframe: Administered weekly up to week 25 (end of group treatment)